Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection
Sangamo
BioSciences, Inc. today announced that data from its program to develop a ZFP Therapeutic for HIV/AIDS were presented at the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC. The study represents the first demonstration that cells can be made resistant to HIV infection by treatment with Sangamo's proprietary zinc finger DNA-binding pr...
Bioscience at Biology Products
Mouse Anti-Mouse Glutathione S-transferase M1 (GSTM1) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
Description:Anti-GSTM1 Monoclonal Antibody Store vial at -20 C prior to opening. Aliquot contents and freeze at -20 C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. <b...
Company:Lifespan
Biosciences
Rabbit Anti-Human Vitamin K-dependent Protein S (PROS1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Description:Anti-PROS1 Polyclonal Antibody not assigne...
Company:Lifespan
Biosciences
Qpatch HT from Sophion Bioscience
Description:Sophions newly introduced QPatch HT is taking automated patch clamping to a new and even more powerful level. With its ability to generate thousands of high quality data points daily, QPatch HT is enabling new screening paradigms in ion channel drug discovery and safety testing. Automated patch clamping with the same high quality afforded by conventional patch clamping can now be applied in all p...
Company:Sophion
BioscienceRabbit Anti-Human Sirtuin (silent mating type information regulation 2, S.cerevisiae, homolog) 7 (SIRT7) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Description:Sirtuin 7 (SIRT7) Rabbit anti-Human Polyclonal Antibody Long term: -20C; Short term: +4C...
Company:Lifespan
Biosciences
BD Pathway 435 confocal bioimager from BD Biosciences - Bioimaging
Description:The BD Pathway 435 is an affordable, compact benchtop imager compatible with multiwell plates and slides, providing a broad array of automated imaging capabilities. The system rapidly acquires high-resolution images with high-performance laser autofocus, true confocal optics, flexible computer-controlled excitation and emission filter changers, and a long-life alignment-free metal halide lamp.<p...
Company:BD
Biosciences - Bioimaging
More>>
Bioscience at Biology Technology
Bioscience at Medicine News
Bioscience at Medicine Products
Bioscience at Medicine Technology
YM BioSciences Announces Secondary Efficacy and Safety Findings in
Randomized Phase IIB Aerolef Trial
- Company Announces Lead Investigator for U.S. Trial - MISSISSAUGA, ON, July 11, 2007 /PRNewswire-FirstCall/ - YM
BioSciences Inc. , an oncology company that identifies, developsand commercializes differentiated products for patients worldwide,today announced results of secondary endpoint data from its 99patient, randomized, placebo-controlled, multi-center Phase IIbtrial (DLXLEF-AP4) with...
YM BioSciences Announces Preclinical Data Confirming Nimotuzumab
Binds to the EGF Receptor and Potentiates Radiotherapy
MISSISSAUGA, ON, July 09, 2007 /PRNewswire-FirstCall/ - YM
BioSciences Inc. , an oncology company that identifies, developsand commercializes differentiated products for patients worldwide,today announced that a study presented by investigators from KinkiUniversity School of Medicine and Kyoto University at the 11thmeeting of The Japanese Association for Molecular Target Therapy ofCancer...
Sangamo BioSciences Announces Presentation of Phase 1 ZFP
Therapeutic Data at American Diabetes Association Meeting
Presentation Details Statistically Significant Clinical Results forSB-509 in Development for Treatment of Diabetic Neuropathy CHICAGO, June 22, 2007 /PRNewswire-FirstCall/ -- Sangamo
BioSciences, Inc. announced today the presentation of encouragingPhase 1 clinical data from its ZFP Therapeutic(TM) program at the67th Scientific Sessions of the American Diabetes Association(ADA). As disclose...
Neurocrine Biosciences Announces New Research Studies Presented at
APSS Reveal Significant Under-Diagnosis of Insomnia
Data Highlights the Impact of Insomnia on Healthcare System andWorker Productivity SAN DIEGO, June 12, 2007 /PRNewswire-FirstCall/ -- Neurocrine
Biosciences, Inc. announced today that results from severalresearch studies on the impact of chronic primary and transientinsomnia were presented this week at the Associated ProfessionalSleep Societies (APSS) Annual Meeting. APSS highlights show t...
Hana Biosciences Presents Data On Two Programs At the American
Society of Clinical Oncology Annual Meeting
* Preclinical study evaluating a clinically relevant model ofnormal human skin found that Menadione was the only agent capableof abrogating the cytotoxic effect of erlotinib * Phase I singleagent Marqibo(r) showed OPTISOME(tm) agent was generally welltolerated in metastatic melanoma patients with an adverse eventprofile similar to conventional vincristine SOUTH SAN FRANCISCO, Calif...
More>>